CytomX Therapeutics Inc (CTMX) — Free Cash Flow Generation Index
CytomX Therapeutics Inc (CTMX) has a Free Cash Flow Generation Index of 0.99x as of March 2023. Free cash flow of $9.30 Million represents 1% of operating cash flow ($9.35 Million). Read CTMX total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Free Cash Flow Generation Index (2014–2020)
Historical FCF Generation Index trend for CytomX Therapeutics Inc across 3 annual periods. Explore CTMX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for CytomX Therapeutics Inc (2014–2020)
Year-by-year Free Cash Flow Generation Index for CytomX Therapeutics Inc. For the full company profile including market capitalisation, see how much is CytomX Therapeutics Inc worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.56x | $2.95 Million | $5.26 Million | $2.31 Million | ▼ -43.4% |
| 2017 | 0.99x | $168.81 Million | $170.37 Million | $1.56 Million | ▲ +4.6% |
| 2014 | 0.95x | $30.14 Million | $31.80 Million | $1.66 Million | — |